Global Market for Wound Closure Products to Reach $4.6 Billion in 2016; European Market for Electrosurgical Devices to Reach $140 Million in Sales by 2016

FARMINGTON, Conn., Nov. 6, 2012 /PRNewswire-iReach/ -- Research universities such as Columbia, New York University, Northwestern and the University of California system receive hefty incomes through licensing royalties from medical devices or technologies that were discovered and patented at their institution. For example, Wake Forest University licensed patents for a negative-pressure wound-therapy device to Kinetic Concepts Inc. in 1993, which has brought in $500 million for the school since then.

(Photo: http://photos.prnewswire.com/prnh/20121106/CG07254)

For researchers, medical equipment companies, and investors who want to learn more about what the current and future shape of the market for wound closure technologies and biomaterials and electrosurgical devices, Global Information Inc (GII) recommends three noteworthy market research reports from our premium research partners.

US Markets for Current and Emerging Wound Closure Technologies

Nearly 100 million wounds were treated in U.S. hospitals in 2011. Treatment of these wounds generated over $3.8 billion in wound closure product sales (including traditional products such as sutures, stapling systems, and wound closure strips, as well as emerging products such as surgical sealants and glues, energy-based closure devices, automated suturing products, and negative pressure wound therapy systems).

Medtech Insight's new report presents a detailed overview of the U.S. current and emerging wound closure products market. Major topics covered by this report include a an overview of the physiology of wound closure; a discussion of traditional wound closure products such as sutures, stapling products, and wound closure strips; a discussion of emerging wound closure products such as surgical sealants and glues, energy-based closure devices, automated suturing devices, and negative pressure wound therapy products; and analyses of the sales and leading competitors in each of these markets.

An Executive Summary for this report and free sample pages from the full document are available at http://www.giiresearch.com/report/mh107961-wound-closure.html

European Electrosurgical Devices Market

In 2011, the total electrosurgical devices market in Europe was valued at nearly $480 million. Over the forecast period covered by this report, the value of this market is projected to grow at a compound annual rate of greater than 5.0%, increasing by more than $140.0 million in sales by the year 2016. While all segments are projected to maintain stable and moderate growth, the largest market segment - thermal ligature devices - is projected to increase at the highest compound annual rate due to strong demand, growing utilization, introduction of several new, next-generation devices, and the clinical and cost efficacy of electrothermal products.

This report provides insight and analysis for selected traditional and specialized electrosurgical generator systems, handheld instruments and accessories, thermal ligature systems and next-generation electrosurgical products.

An Executive Summary for this report and free sample pages from the full document are available at http://www.giiresearch.com/report/mh253251-european-electrosurgical-devices-market.html

US Markets for Wound Care Biomaterials 2012

Driven by favorable demographic factors, as well as the increasing demand for greater cost efficiencies, adoption of premium-priced negative-pressure wound therapy (NPWT) systems will overcome slower growth in the advanced wound dressing segment and facilitate moderate revenue expansion in the overall US market for wound care biomaterials through 2016.

Companies covered in this report include: 3M Health Care, Albahealth, ATMOS, Bard Peripheral Vascular, BSN medical, Coloplast, ConvaTec, Covidien, Cura Surgical, Derma Sciences, DeRoyal, Ethicon, Ferris Manufacturing, Genadyne Biotechnologies, Gentell, Healthpoint Biotherapeutics, HemCon Medical Technologies, Hollister Wound Care, Human BioSciences, Innovative Therapies, Integra LifeSciences, Kalypto Medical, Lohmann & Rauscher International, McKesson, Medela, Medline Industries, Medtronic, Molnlycke Health Care, Ohio Medical Corporation, PolyRemedy, Premco Medical Systems, Prospera, SANUWAVE Health, Smith & Nephew, Spiracur, Systagenix, Talley Group, UDL Laboratories, and Vomaris Innovations.

An Executive Summary for this report and free sample pages from the full document are available at http://www.giiresearch.com/report/mrg251875-us-markets-wound-care-biomaterials.html

About Global Information Inc. Global Information (GII) (http://www.giiresearch.com) is an information service company partnering with over 300 research companies around the world. Global Information has been in the business of distributing technical and market research for more than 25 years. Expanded from its original headquarters in Japan, Global Information now has offices in Korea, Taiwan, Singapore, Europe and the United States.

Media Contact: Jeremy Palaia Global Information, Inc., 1-860-674-8796, Press@gii.co.jp

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

SOURCE Global Information Inc.

Copyright 2012 PR Newswire